Avacta and Leeds University Awarded £3.8m Medical Research Council Funding to Develop New Diagnostic Tests
Avacta collaborates to develop rapid tests to differentiate between viral and bacterial infections and to differentiate bacterial strains
Avacta collaborates to develop rapid tests to differentiate between viral and bacterial infections and to differentiate bacterial strains
New diagnostic test for the detection of the Zika virus now available for use on fully automated Panther system
Blood banks will use the new test to screen donated blood in potential endemic areas of the US
Certified reference material appropriate for a wide range of retention index systems
Dr Yves Aubin, Research Scientist at Health Canada, spoke to SelectScience® about his research using NMR to study the structure of biosimilar molecules in the pharmaceutical industry
Commercially available xMAP® MultiFLEX™ Zika RNA assay, designed by GenArraytion, Inc., detects 6 genetic targets of Zika virus
Bridging the gap between analytical and process Protein A chromatography
PCR-based Assay Runs on the ARIES® System, a Sample to Answer Platform
Key partners add to growing list of academic institutions making reagents available
The research will be carried out at Plasticell and in the laboratory of Dr. Eva Szegezdi at the Apoptosis Research Centre, NUI Galway
Beckman Coulter addresses critical factors for clinical laboratories to move healthcare forward
SelectScience Introduces New On-Line Directory
PAXgene Blood ccfDNA enhances handling and workflow convenience for liquid biopsy applications in prenatal testing and cancer research
Highly specific assays allow for detection of minor allele frequencies down to 0.1%
Applications include smart wound healing and how plants can protect themselves from toxins
Microfocus beamline enables scientists to work with very small crystal samples of molecules taken from skin cancer proteins